Evidence map›Paper›PMID 24828009›Full record

ArticleScientific reports2014

Imaging single chiral nanoparticles in turbid media using circular-polarization optical coherence microscopy.

Pengfei Zhang, Kalpesh Mehta, Shakil Rehman, Nanguang Chen

Abstract read
In one paragraph

Article in Scientific reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Plasmonic Nanoparticles: Advanced Researches (II).Advances in experimental medicine and biology · 2021
    Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Pengfei Zhang1] Optical Bioimaging Lab, Department of Bioengineering, National University of Singapore, 7 Engineering Drive 1, Singapore 117576 [2].
Kalpesh Mehta1] NUS Graduate School for Integrative Sciences and Engineering, National University of Singapore, 28 Medical Drive, Singapore 117456 [2].
Shakil Rehman1] Optical Bioimaging Lab, Department of Bioengineering, National University of Singapore, 7 Engineering Drive 1, Singapore 117576 [2] BioSystems and Micromechanics IRG, Singapore MIT Alliance for Research and Technology, 1 Create Way, Singapore 138602.
Nanguang Chen1] Optical Bioimaging Lab, Department of Bioengineering, National University of Singapore, 7 Engineering Drive 1, Singapore 117576 [2] NUS Graduate School for Integrative Sciences and Engineering, National University of Singapore, 28 Medical Drive, Singapore 117456.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Optical coherence tomography (OCT) is a widely used structural imaging method. However, it has limited use in molecular imaging due to the lack of an effective contrast mechanism. Gold nanoparticles have been widely used as molecular probes for optical microcopy based on Surface Plasmon Resonance (SPR). Unfortunately, the SPR enhanced backscattering from nanoparticles is still relatively weak compared with the background signal from microscopic structures in biological tissues when imaged with OCT. Consequently, it is extremely challenging to perform OCT imaging of conventional nanoparticles in thick tissues with sensitivity comparable to that of fluorescence imaging. We have discovered and demonstrated a novel approach towards remarkable contrast enhancement, which is achieved by the use of a circular-polarization optical coherence microscopy system and 3-dimensional chiral nanostructures as contrast agents. By detecting the circular intensity differential depolarization (CIDD), we successfully acquired high quality images of single chiral nanoparticles underneath a 1-mm-thick tissue -mimicking phantom.

Indexed as

Contrast MediaDiagnostic ImagingFluorescenceGoldMetal NanoparticlesMicroscopyNanostructuresPhantoms, ImagingTomography, Optical CoherenceContrast MediaGold

Identifiers

PMID24828009
PMCPMC4021320

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.